Docket Number:14A-941024
Inventor:Shu-Mei Liang, Na-Sheng Lin, Yau-Heiu Hsu, Jia-The Liao
IP Status:EP 1942188 B1、CN 101611144 B、VN 11252、MY-148142-A、TW I412588、PH 1/2009/501333
Abstract:
We have developed BaMV as a vector to express antigen and pharmaceutical agents in plants. This system can produce useful and large quantities of proteins in plants. In this invention, we have successfully engineered BaMV as a vaccine vector expressing the antigenic epitope(s) of the capsid protein VP1 of foot-and-mouth disease virus (FMDV). we used the chimeric virions to immunize swine that results in marked increase in titer of anti-FMDV nentralizing antibodies. In addition, we found all swine immunized with chimeric virions are completely protected against FMDV challenge.
Fields of Application:
Vaccine, pharmaceutical agents
Advantages when compared to the existing technologies:
- Economical production.
- Lack of contamination with animal pathogens.
- High copy numbers.
- Short infection period.
- No requirement for gene transformation and plant regeneration.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
